|
|
| WIN-901X / WhanIn (0 Trials) |
|
| W0180 / Pierre Fabre (0 Trials) |
|
| Wafermine (ketamine) / iX Biopharma (1 Trials) |
|
| Wainua (eplontersen) / Ionis, AstraZeneca (0 Trials) |
|
| Wakix (pitolisant) / Ferrer International, Paragon Biosci, Aculys Pharma (11 Trials) |
|
| Wan Su Lin (isophane insulin biosimilar) / Fosun Pharma (0 Trials) |
|
| Wan Su Lin 30R (isophane insulin biosimilar 70% + recombinant human insulin biosimilar 30%) / Fosun Pharma (0 Trials) |
|
| warfarin / Generic mfg. (150 Trials) |
|
| WAS gene therapy / Genethon (1 Trials) |
|
| Waylivra (volanesorsen) / Novartis, SOBI (2 Trials) |
|
| WB002 / Weben Pharma (0 Trials) |
|
| WB007 / Whitecap Biosci (0 Trials) |
|
| WB100 / Weben Pharma (0 Trials) |
|
| WBI-2100 / Welichem (0 Trials) |
|
| WBP3425 / Wuxi Biocity (0 Trials) |
|
| WDB002 / Revolution Medicines (0 Trials) |
|
| WDVAX / Dana-Farber Cancer Institute (1 Trials) |
|
| welgenaleucel (UWC19) / UWELL Biopharma (0 Trials) |
|
| Welireg (belzutifan) / Merck (MSD) (3 Trials) |
|
| Wepox (epoetin alfa biosimilar) / Wockhardt (0 Trials) |
|
| WEVEE VLP / Emergent Biosolutions (0 Trials) |
|
| Wezlana (ustekinumab-auub) / Amgen (0 Trials) |
|
| Wharton's Jelly Mesenchymal stem cells / Stem Cells Arabia (0 Trials) |
|
| wheat-OIT / DBV Technologies (0 Trials) |
|
| White-C (filgrastim biosimilar) / Shandong Kexing Bioproducts (0 Trials) |
|
| WI-211094 / WhanIn (0 Trials) |
|
| WIB-801C / WhanIn (0 Trials) |
|
| WIB-901H / WhanIn (0 Trials) |
|
| WIBP Inactivated COVID-19 vaccine (Omicron) / Sinopharm (0 Trials) |
|
| WIBP-CorV / Sinopharm (0 Trials) |
|
| WID-2101 / WhanIn (0 Trials) |
|
| WIE-1902 / WhanIn (0 Trials) |
|
| WIG-1810 / WhanIn (0 Trials) |
|
| WII-2002 / WhanIn (0 Trials) |
|
| Wilate (human factor VIII/von Willebrand factor) / Octapharma (6 Trials) |
|
| Willfact (human von Willebrand factor) / LFB SA (0 Trials) |
|
| WIN-34B / Hamsoa Pharma (0 Trials) |
|
| WIN-902A / WhanIn (0 Trials) |
|
| Winlevi (clascoterone cream 1%) / Cassiopea (6 Trials) |
|
| Winrevair (sotatercept) / BMS, Merck (MSD) (9 Trials) |
|
| WinRho SDF (rho(d) immune globulin (human)) / Kamada (0 Trials) |
|
| WIT-2001 / WhanIn (0 Trials) |
|
| withania somnifera / Oasis (0 Trials) |
|
| WJ01075 / Suzhou Junjing Biomed (0 Trials) |
|
| WJ05129 / Shanghai Junshi Biosci (0 Trials) |
|
| WJ1075 / Wigen Biomedicine, Shanghai Junshi Biosci (0 Trials) |
|
| WM-A1-3389 / WMBIO (0 Trials) |
|
| WM-D2 / WMBIO (0 Trials) |
|
| WM-S1 / WMBIO (0 Trials) |
|
| WN1316 / Wakunaga, Neugen Pharma, Sawai Pharma (0 Trials) |
|
| WNT974 / Novartis (1 Trials) |
|
| WO-12 / Pfizer, Western Oncolytics (0 Trials) |
|
| WO-H1 / Western Oncolytics (0 Trials) |
|
| WO-VET-S3 / Western Oncolytics (0 Trials) |
|
| Wosulin 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt (0 Trials) |
|
| Wosulin 50/50 (recombinant human insulin biosimilar 50% + isophane insulin biosimilar 50%) / Wockhardt (0 Trials) |
|
| Wosulin N (isophane insulin biosimilar) / Wockhardt (0 Trials) |
|
| Wosulin R (recombinant human insulin biosimilar) / Wockhardt (0 Trials) |
|
| Woulgan (yeast beta-glucan) / ArcticZymes (0 Trials) |
|
| WP-REP1 / Wize Pharma (0 Trials) |
|
| WP1066 / Moleculin, WPD Pharma (0 Trials) |
|
| WP1096 / Moleculin (0 Trials) |
|
| WP1097 / Moleculin (0 Trials) |
|
| WP1122 / Moleculin, CNS Pharma, WPD Pharma (0 Trials) |
|
| WP1220 / WPD Pharma (0 Trials) |
|
| WP1244 / CNS Pharma (0 Trials) |
|
| WP1732 / WPD Pharma (0 Trials) |
|
| WP1874 / CNS Pharma (0 Trials) |
|
| WPD101 / WPD Pharma (0 Trials) |
|
| WRAIR GSK TDEN vaccine / GSK, U.S. Army Medical Research and Development Command (0 Trials) |
|
| WSD0922 / Wayshine Biopharm (0 Trials) |
|
| WSD1227 / Wayshine Biopharm (0 Trials) |
|
| WT1 TCR-transduced T-cell therapy / Takara (0 Trials) |
|
| WT2725 / Sumitomo Pharma (0 Trials) |
|
| WT4869 / Sumitomo Pharma (0 Trials) |
|
| WT501 / Wellstat (0 Trials) |
|
| WTX-124 / Werewolf Therap (0 Trials) |
|
| WTX-330 / Werewolf Therap (0 Trials) |
|
| WTX212 / Westlake Therap (0 Trials) |
|
| WU ALLO CART / Wugen (0 Trials) |
|
| WU CART 002 / Wugen (0 Trials) |
|
| WU CART 007 / Wugen (0 Trials) |
|
| Wu-5 / Shanghai Jiao Tong University (0 Trials) |
|
| WU-NK-101 / Wugen (0 Trials) |
|
| wujia yizhi granules (KH110) / Chengdu Kanghong Pharma (0 Trials) |
|
| WVE-003 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-004 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-005 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-120101 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-120102 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-N531 / Wave Life Sciences (0 Trials) |
|
| WVT078 / Novartis (0 Trials) |
|
| WX-037 / Heidelberg Pharma (0 Trials) |
|
| WX-066 / Qilu Pharma (0 Trials) |
|
| WX-554 / Heidelberg Pharma (0 Trials) |
|
| WX-UK1 / RedHill (0 Trials) |
|
| WX008 / Sino Biopharm, WuXi AppTec (0 Trials) |
|
| WX047 / Sino Biopharm, WuXi AppTec (0 Trials) |
|
| WXFL078 / Guangdong Zhongsheng Pharma (0 Trials) |
|
| WXFL10030390 / Guangzhou JOYO Pharma (0 Trials) |
|
| WXFL10203614 / Wuxi Fuxin (0 Trials) |
|
| WXFL1024H251 / Sino Biopharm (0 Trials) |
|
| WXSH0011 / WuXi AppTec (0 Trials) |
|
| WXSH0213 / Guangdong Zhongsheng Pharma (0 Trials) |
|
| WYA-152038 / Ligand, Pfizer (0 Trials) |
|
| WYE-125132 / Pfizer (0 Trials) |
|
| Wynzora (calcipotriene/betamethasone dipropionate) / MC2 Therap, Almirall (0 Trials) |
|
| WZ4002 / Dana-Farber Cancer Institute (0 Trials) |
|
| WZTL-002 / Wellington Zhaotai Therapies (0 Trials) |